Salivary antioxidants in patients with systemic sclerosis

Journal of Oral Pathology and Medicine

Volumn 43, Issue 1, 2014, Pages 61-68

  Zalewska, Anna ^a   Knaś, Malgorzata ^a   Gińdzieńska Sieśkiewicz, Ewa ^a   Waszkiewicz, Napoleon ^a   Klimiuk, Anna ^a   Litwin, Katarzyna ^a   Sierakowski, Stanislaw ^a   Waszkiel, Danuta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Antioxidants; Saliva; Systemic sclerosis

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PEROXIDASE; URIC ACID; ANTIOXIDANT; FREE RADICAL; SALIVA PROTEIN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIP BIOPSY; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; SALIVATION; SCHIRMER TEST; STOMATOLOGY; SYSTEMIC SCLEROSIS; XEROSTOMIA; ATROPHY; CASE CONTROL STUDY; CHEMISTRY; COLORIMETRY; COMPARATIVE STUDY; DEVICES; FEMALE; FIBROSIS; HEALTH SURVEY; METABOLISM; MINOR SALIVA GLAND; PATHOLOGY; PERIODONTICS; PHYSIOLOGY; SALIVA; SECRETION (PROCESS); SECRETION RATE; XEROPHTHALMIA;

ADULT; AGED; ANTIOXIDANTS; ATROPHY; CASE-CONTROL STUDIES; COLORIMETRY; DMF INDEX; FEMALE; FIBROSIS; FREE RADICALS; HUMANS; MIDDLE AGED; PERIODONTAL INDEX; PEROXIDASES; SALIVA; SALIVARY GLANDS, MINOR; SALIVARY PROTEINS AND PEPTIDES; SCLERODERMA, SYSTEMIC; SECRETORY RATE; SUPEROXIDE DISMUTASE; URIC ACID; XEROPHTHALMIA; XEROSTOMIA;

EID: 84891830171     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12084     Document Type: Article

References (34)

1. Joseph A, Brasington R, Kahl L, et al. Immunologic rheumatic disorders. J Allergy Clin Immunol 2010; 125: S204-15.
2. Dooley A, Bruckdorfer KR, Abraham DJ Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants. Cardiol Res Pract 2012; 2012: Art. ID. 521958. doi: 10.1155/2012/521958.
3. Mason GI, Hamburger J, Matthews JB. Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis. Ann Rheum Dis 2000; 59: 183-9.
4. Romano E, Manetti M, Guiducci S, et al. The genetics of systemic sclerosis: an update. Clin Exp Rheumatol 2011; 29: S75-86.
5. Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann NY Acad Sci 2010; 1183: 267-87.
6. Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15: 1077-81.
7. Rose NR, Mackay IR. The autoimmune diseases. San Diego: Elsevier Academic Press, 2006.
8. Osial TA Jr, Whiteside TL, Buckingham RB, et al. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983; 26: 500-8.
9. Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Sjögren's syndrome in progressive systemic sclerosis. J Rheumatol 1988; 15: 965-8.
10. Andonopoulos AP, Drosos AA, Skopouli FN, et al. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis A comparative study. Clin Exp Rheumatol 1989; 7: 203-5.
11. Rasker JJ, Jayson MI, Jones DE, et al. Sjögren's syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 1990; 19: 57-65.
12. Hebbar M, Gillot JM, Hachulla E, et al. Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis. Arthritis Rheum 1996; 39: 1161-5.
13. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006; 2: 134-44.
14. Dooley A, Gao B, Bradley N, et al. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology 2006; 45: 676-84.
15. Ogawa F, Shimizu K, Muroi E, et al. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology 2006; 45: 815-8.
16. Shimizu K, Ogawa E, Muroi E, et al. Increased serum levels of nitrotyrosine, a marker for peroxynitrite production, in systemic sclerosis. Clin Exp Rheumatol 2007; 25: 281-6.
17. Svegliati S, Cancello P, Sambo P, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005; 280: 36474-82.
18. Su H, Baron M, Benarroch M, et al. Altered salivary redox homeostasis in patients with systemic sclerosis. J Rheumatol 2010; 37: 1858-63.
19. Committee SfSCotARADaTC Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1982; 23: 581-90.
20. Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
21. Inoue H, Ono K, Masuda W, et al. Gender difference in unstimulated whole saliva flow rate and salivary gland sizes. Arch Oral Biol 2006; 51: 1055-60.
22. WHO. Oral health surveys: basic methods. World Health Organization: Genewa, 1997.
23. Vitali C, Bombardieri S, Jonsson R, et al. Classification Criteria for Sjögren's syndrome: a revised version of the European criteria proposed by American- European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
24. Schirmer O. Studien zur physiologie der tranenabsonderung und tranenabfuhr. Arch Opthalmol 1903; 56: 197-221.
25. Zalewska A, Knaś M, Waszkiewicz N, et al. Rheumatoid arthritis patients with xerostomia have reduced production of key salivary constituents. Oral Surg Oral Med Oral Pathol 2013; 115: 483-90.
26. Mansson-Rahemtulla B, Baldone DC, Pruitt KM, et al. Specific assays for peroxidases in human saliva. Arch Oral Biol 1986; 31: 661-8.
27. Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J 2010; 55: 238-44.
28. Nagler RM, Klein I, Zarzhevsky N, et al. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med 2002; 32: 268-77.
29. Kanehira T, Shibata K, Kashiwazaki H, et al. Comparison of antioxidant enzymes in saliva of eldery smokers and non-smokers. Gerodontology 2006; 23: 38-42.
30. Ogawa F, Shimizu K, Muroi E, et al. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol 2011; 30: 921-5.
31. Cucoranu I, Clempus R, Dikalova A, et al. NAD(P)H oxidase-4 mediates transforming growth factor-beta-1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005; 97: 900-7.
32. Weiner D, Khankin EV, Levy Y, et al. Effects of cigarette smoke borne reactive nitrogen species on salivary alpha-amylase activity and protein modification. J Physiol Pharmacol 2009; 60(suppl. 5): 127-32.
33. Ergun S, Troşala SC, Warnakulasuriya S, et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. J Oral Pathol Med 2011; 40: 286-93.
34. Giebultowicz J, Wroczyński P, Samolczyk-Wanyura D. Comparison of antioxidant enzymes activity and the concentration of uric acid in the saliva of patients with oral cavity cancer, odontogenic cysts and healthy subjects. J Oral Pathol Med 2011. doi.10.1111/j.1600-0714.2011.01045.x.